09:20 AM EDT, 04/15/2026 (MT Newswires) -- Health care stocks were rising pre-bell Wednesday with the State Street Health Care Select Sector SPDR ETF ( XLV ) 0.1% higher and the iShares Biotechnology ETF (IBB) up 0.4%.

Mesoblast (MESO) shares were up more than 4% after the company said it acquired an exclusive worldwide license to a chimeric antigen receptor technology platform for augmentation of therapeutic mesenchymal lineage stromal cell products.

ARS Pharmaceuticals ( SPRY ) stock was up more than 1% after the company said Health Canada has approved its neffy 2mg nasal spray for the emergency treatment of anaphylaxis.

Immutep ( IMMP ) shares rose by more than 178% after the company said the US Food and Drug Administration has granted orphan drug designation to eftilagimod alfa for the treatment of soft tissue sarcoma, a rare cancer.